List Trials for Newly Diagnosed Acute Lymphoid Leukemia (ALL)

Acute Lymphoid Leukemia (AML)

 

Entospletinib with Vincristine and Dexamethasone for Acute Lymphoid Leukemia (20150518)
A Phase 1b, Open-Label, Dose Escalation and Expansion Study Evaluating the Safety and Efficacy of Entospletinib (GS-9973) with Vincristine and Dexamethasone in Adult Subjects with Relapsed or Refractory Acute Lymphoid Leukemia (ALL)

Investigator: Ryan Cassaday, MD;   Conditions: Acute Lymphoid Leukemia;    Status: Recruiting;   Study ID: NCT02404220